P.4.041 Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

✍ Scribed by B. Winblad; K. Engedal; H. Soininen; F.R.J. Verhey; G. Waldemar; A. Wimo; A.-L. Wetterholm; A. Haglund; R. Zhang; L. Burger; R. Schindler

• Book ID: 119577269
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 286 KB
• Volume: 13
• Category: Article
• ISSN: 0924-977X
• DOI: 10.1016/s0924-977x(03)92235-8